HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase
Top Cited Papers
- 6 November 2011
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 480 (7377) , 379-382
Abstract
Mutations in SAMHD1 protein are associated with the human autoimmune disease Aicardi–Goutières syndrome, and SAMHD1 was recently shown to be responsible for restriction of HIV-1 replication in myeloid cells. Ian Taylor and colleagues reveal a previously unknown function of SAMHD1 that could explain its antivirus role. They provide a crystal structure of the catalytic core of SAMHD1 and show that it is a dGTP-stimulated triphosphohydrolase that hydrolyses dNTPs, the building blocks of DNA. This activity may prevent reverse transcription and viral synthesis of complementary DNA by keeping the concentration of cellular dNTPs at a low level. SAMHD1, an analogue of the murine interferon (IFN)-γ-induced gene Mg11 (ref. 1), has recently been identified as a human immunodeficiency virus-1 (HIV-1) restriction factor that blocks early-stage virus replication in dendritic and other myeloid cells2,3 and is the target of the lentiviral protein Vpx, which can relieve HIV-1 restriction4,5,6,7. SAMHD1 is also associated with Aicardi–Goutières syndrome (AGS), an inflammatory encephalopathy characterized by chronic cerebrospinal fluid lymphocytosis and elevated levels of the antiviral cytokine IFN-α8. The pathology associated with AGS resembles congenital viral infection, such as transplacentally acquired HIV. Here we show that human SAMHD1 is a potent dGTP-stimulated triphosphohydrolase that converts deoxynucleoside triphosphates to the constituent deoxynucleoside and inorganic triphosphate. The crystal structure of the catalytic core of SAMHD1 reveals that the protein is dimeric and indicates a molecular basis for dGTP stimulation of catalytic activity against dNTPs. We propose that SAMHD1, which is highly expressed in dendritic cells, restricts HIV-1 replication by hydrolysing the majority of cellular dNTPs, thus inhibiting reverse transcription and viral complementary DNA (cDNA) synthesis.Keywords
This publication has 30 references indexed in Scilit:
- Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 proteinNature, 2011
- SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by VpxNature, 2011
- A novel fluorescence-based assay for the rapid detection and quantification of cellular deoxyribonucleoside triphosphatesNucleic Acids Research, 2011
- Ribonucleoside Triphosphates as Substrate of Human Immunodeficiency Virus Type 1 Reverse Transcriptase in Human MacrophagesJournal of Biological Chemistry, 2010
- A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cellsNature, 2010
- A Cellular Restriction Dictates the Permissivity of Nondividing Monocytes/Macrophages to Lentivirus and Gammaretrovirus InfectionCell Host & Microbe, 2009
- The Human Immunodeficiency Virus Type 2 Vpx Protein Usurps the CUL4A-DDB1 DCAF1 Ubiquitin Ligase To Overcome a Postentry Block in Macrophage InfectionJournal of Virology, 2009
- Trex1 Prevents Cell-Intrinsic Initiation of AutoimmunityCell, 2008
- Reduced dNTP Binding Affinity of 3TC-resistant M184I HIV-1 Reverse Transcriptase Variants Responsible for Viral Infection Failure in MacrophageJournal of Biological Chemistry, 2008
- [20] Processing of X-ray diffraction data collected in oscillation mode1997